𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Direct identification by PCR of EBV types and variants in clinical samples

✍ Scribed by Falk, Kerstin I.; Zou, Jie-Zhi; Lucht, Erik; Linde, Annika; Ernberg, Ingemar


Book ID
102646920
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
716 KB
Volume
51
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Both Epstein-Barr virus (EBV) type A and type B, and variants of type A, were identified simultaneously by polymerase chain reaction (PCR) amplification of a DNA region coding for a 13 amino acid repeat in the Epstein-Barr virus nuclear antigen (EBNA) 6. Whereas this region varies extensively in type A isolates, no variation was seen in type B isolates. When a repetitive region in the LMP1-coding region was amplified by PCR, it was possible to distinguish individual variants of type B isolates from each other. Forty-two saliva samples from HIV-1-carrying individuals were examined for the presence of type A and type B virus. Both types and multiple variants of each type were found with a much higher frequency than in the saliva samples from healthy individuals. Type A EBV alone was detected in mouthwash samples from 6 infectious mononucleosis (IM) patients. Both type A and B were detected in the peripheral blood Blymphocytes (PBL) from 1 healthy individual. The same type A variant was demonstrated both in PBL and in the mouthwash sample from another healthy individual. In this study it was shown that a combination of the EBNA 6-and LMP 1-specific PCRs followed by Southern hybridisation can be used to identify both type A and type B virus, as well as to distinguish between multiple variants of the same strain, in saliva and B-cells from both healthy and immunosuppressed individuals.


📜 SIMILAR VOLUMES


Semiquantitative PCR analysis of Epstein
✍ Astrid Meerbach; Bernd Gruhn; Renate Egerer; Udo Reischl; Felix Zintl; Peter Wut 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract The laboratory diagnosis of primary and reactivated Epstein‐Barr virus (EBV) infection is based on serologic methods in immunocompetent patients. However, in immunocompromised patients, serologic data are difficult to interpret and do not often correlate with clinical data. In order to

Real-time identification of Pseudomonas
✍ Richard I. Jaffe; Janae D. Lane; Christopher W. Bates 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract __Pseudomonas aeruginosa__ has emerged as one of the most problematic Gram‐negative nosocomial pathogens. Bacteremia caused by __P. aeruginosa__ is clinically indistinguishable from other Gram‐negative infections although the mortality rate is higher. This microorganism is also inherent